Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial
Pío López, Eduardo López-Medina, Xavier Sáez‐Llorens, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

A narrative review of norovirus epidemiology, biology, and challenges to vaccine development
Katherine B. Carlson, Anne Dilley, Thomas O’Grady, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 17
Norovirus replication, host interactions and vaccine advances
B. V. Venkataram Prasad, Robert L. Atmar, Sasirekha Ramani, et al.
Nature Reviews Microbiology (2025)
Closed Access | Times Cited: 1
Molnupiravir inhibits human norovirus and rotavirus replication in 3D human intestinal enteroids
Nânci Santos-Ferreira, Jana Van Dycke, Winston Chiu, et al.
Antiviral Research (2024) Vol. 223, pp. 105839-105839
Closed Access | Times Cited: 6
Safety and immunogenicity of a bivalent norovirus vaccine candidate in infants from 6 weeks to 5 months of age: A phase 2, randomized, double-blind trial
Xavier Sáez‐Llorens, Rodrigo DeAntonio, Eduardo López-Medina, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Broadly neutralizing antibodies targeting pandemic GII.4 variants or seven GII genotypes of human norovirus
Juyeon Park, Lisa C. Lindesmith, Adam S. Olia, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 788
Closed Access
Attitudes toward a future norovirus vaccine among members of an integrated healthcare delivery system in Portland, Oregon, 2016-2017
Holly C. Groom, Mark A. Schmidt, Laura E. Calderwood, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Extraction, purification, structural features, and pharmacological properties of polysaccharides from Houttuynia cordata: A review
Jing Liu, Junbo Zou, Jingyuan Wang, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135230-135230
Closed Access | Times Cited: 1
Bivalent norovirus mRNA vaccine elicits cellular and humoral responses protecting human enteroids from GII.4 infection
Elena N. Atochina‐Vasserman, Lisa C. Lindesmith, Carmen Mirabelli, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Advances in human norovirus research: Vaccines, genotype distribution and antiviral strategies
Junli Chen, Zuolin Cheng, Jing Chen, et al.
Virus Research (2024) Vol. 350, pp. 199486-199486
Open Access | Times Cited: 1
Discovery medicine – the HVTN's iterative approach to developing an HIV-1 broadly neutralizing vaccine
Troy Martin, Sam T. Robinson, Yunda Huang
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 6, pp. 290-299
Open Access | Times Cited: 3
Lipid nanoparticles as adjuvant of norovirus VLP vaccine augment cellular and humoral immune responses in a TLR9- and type I IFN-dependent pathway
Weiqian Dai, Man Xing, Lingjin Sun, et al.
Journal of Virology (2024)
Open Access
Production of recombinant norovirus VP1 protein and its antigenic and immunogenic properties
В. А. Лапин, Д. В. Новиков, Е. В. Мохонова, et al.
Journal of microbiology epidemiology immunobiology (2024) Vol. 101, Iss. 5, pp. 661-667
Open Access
Page 1

Scroll to top